Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis is primarily a neurodegenerative disease.
Propentofylline treatment on open field behavior in rats with focal ethidium bromide-induced demyelination in the ventral surface of the brainstem.
New immunological approaches in treating and diagnosing CNS diseases.
Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis.
Nicotine might have a protective effect in the etiology of multiple sclerosis.
Neurological disorders: Differential methylation in multiple sclerosis.
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis.
Experience of gratitude, awe and beauty in life among patients with multiple sclerosis and psychiatric disorders.
Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review.
Iron chelation and multiple sclerosis.
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.
Clinicopathological features in anterior visual pathway in neuromyelitis optica.
Imaging in multiple sclerosis and related disorders.
White matter disease: 'Bright spotty lesions'-a novel NMO-specific MRI feature?
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Claudin Proteins And Neuronal Function.
Pages
« first
‹ previous
…
404
405
406
407
408
409
410
411
412
…
next ›
last »